CURE Pharmaceutical Holding Corp., a specialty pharmaceutical and bioscience company, develops drug formulation and delivery technologies. The company markets CUREfilm dietary supplements, such as Melatonin-based sleep aid CUREfilm. It is also developing CUREfilm prescription and over-the-counter pharmaceutical drugs, including high dose vitamin D3, Sildenafil, PEA and dronabinol combination, Benzocaine, and Isoniazid. In addition, the company researches high dose electrolytes and various actives for veterinary applications. CURE Pharmaceutical Holding Corp. has a development agreement with Therapix Biosciences Ltd. for formulating and developing pharmaceutical products. The company is based in Oxnard, California.